valerates has been researched along with Experimental Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, J; Feng, Y; Gu, H; Huang, L; Huang, T; Jiang, M; Li, B; Pi, C; Xie, K; Xu, L; Xu, X; Zhang, J | 1 |
| Aversa, Z; Baccino, FM; Bonetto, A; Costelli, P; Lucia, S; Minero, VG; Muscaritoli, M; Penna, F; Rossi Fanelli, F | 1 |
| Smith, HJ; Tisdale, MJ; Wyke, SM | 1 |
| Mukerji, P; Smith, HJ; Tisdale, MJ | 1 |
| de la Iglesia, FA; Fitzgerald, JE; Lake, RS; McGuire, EJ; Sanyer, JL; Schardein, JL | 1 |
| Koda, A; Mori, H; Nagai, H; Watanabe, S | 1 |
7 other study(ies) available for valerates and Experimental Neoplasms
| Article | Year |
|---|---|
Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression.
Topics: Adaptation, Physiological; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Immunosuppression Therapy; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; Neoplasms, Experimental; Programmed Cell Death 1 Receptor; Specific Pathogen-Free Organisms; Tumor Microenvironment; Up-Regulation; Valerates | 2021 |
β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Topics: Animals; Body Weight; Cachexia; Down-Regulation; Drug Evaluation, Preclinical; Male; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Neoplasms, Experimental; Random Allocation; Rats; Rats, Wistar; Valerates; Weight Loss | 2011 |
Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate.
Topics: Animals; Arachidonic Acid; Blood Proteins; Disease Models, Animal; Eicosapentaenoic Acid; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Neoplasms, Experimental; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteoglycans; Signal Transduction; Ubiquitin; Valerates; Weight Loss | 2004 |
Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Topics: Animals; Body Weight; Eicosapentaenoic Acid; Humans; Kinetics; Mice; Muscle, Skeletal; Neoplasm Proteins; Neoplasms, Experimental; Proteasome Endopeptidase Complex; Valerates; Wasting Syndrome; Weight Loss | 2005 |
Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil.
Topics: Animals; Biotransformation; Body Weight; Carcinogens; Female; Gemfibrozil; Hypolipidemic Agents; Liver; Liver Neoplasms, Experimental; Male; Mice; Mutagenicity Tests; Mutagens; Neoplasms, Experimental; Pentanoic Acids; Rats; Salmonella typhimurium; Valerates; Xylenes | 1981 |
Allyl isovalerate.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Humans; Mutagenicity Tests; Mutagens; Neoplasms, Experimental; Valerates | 1999 |
Proceedings: Effect of drugs on antibody formation. VII. Tumor immunity.
Topics: Amino Acids, Sulfur; Animals; Antibody Formation; Glycine; Mice; Neoplasms, Experimental; Valerates | 1974 |